Gossamer Bio

Funds raised: $230 million series B round, $100 million series A round

Employees: 55 currently. Plans call for 100 employees by year’s end.

Investors: Hillhouse Capital, Invus, The Baupost Group, Polaris Partners, ARCH Venture Partners and Omega Funds

Headquarters: San Diego

Year founded: 2015

Company description: Gossamer is developing drugs for a swath of disease areas, covering autoimmune, allergy/inflammation, immuno-oncology and fibrosis.

— By going big, Gossamer Bio looks to break the mold...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129